Neoleukin
is a Washington-based biotechnology company that researches and develops novel therapeutics for the treatment of cancer and autoimmune diseases... Read moreNeoleukin
is a Washington-based biotechnology company that researches and develops novel therapeutics for the treatment of cancer and autoimmune diseases... Read more
Annual Revenue
$3.7M
Employees
91
News
Dec 21, 2023
The Business Journals
Neoleukin: Seattle-based Neoleukin folded into New York biotech after merger
Dec 20, 2023
Pharamceutical Technology
Neoleukin: Neurogene concludes merger deal with Neoleukin Therapeutics
Dec 19, 2023
BioSpace
Neoleukin: Neurogene Announces Closing of Merger with Neoleukin Therapeutics and Concurrent Private Placement of $95 Million
Dec 15, 2023
BioSpace
Neoleukin: Neoleukin Therapeutics Announces 1-for-4 Reverse Stock Split
Nov 14, 2023
Marketscreener
Neoleukin: Neoleukin: Q3 Earnings Snapshot
Sep 23, 2023
Life Care News
Neoleukin: Neoleukin Therapeutics Announces 1-for-5 Reverse Stock
Aug 18, 2023
Benzinga
Neoleukin: Neoleukin Therapeutics Recent Insider Activity
Jul 26, 2023
GlobalNewswire
Press Release: Neoleukin : Moore Kuehn Encourages AMNB, SCU, NLTX, and PRDS Investors to Contact Law Firm
Jul 25, 2023
MarketScreener
Neoleukin: NEOLEUKIN THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Neoleukin Therapeutics, Inc. - NLTX
Jul 20, 2023
Global Legal Chronicle
Neoleukin: Neurogene's Merger with Neoleukin
Neoleukin Competitors
1
2
3
4
5
6
7
8
9
10